218 related articles for article (PubMed ID: 8534760)
21. Antifungal susceptibility of Aspergillus species isolated from invasive oral infection in neutropenic patients with hematologic malignancies.
Myoken Y; Sugata T; Myoken Y; Kyo T; Fujihara M; Mikami Y
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Feb; 87(2):174-9. PubMed ID: 10052372
[TBL] [Abstract][Full Text] [Related]
22. Low-dose liposomal amphotericin B in the prevention of invasive fungal infections in patients with prolonged neutropenia: results from a randomized, single-center trial.
Penack O; Schwartz S; Martus P; Reinwald M; Schmidt-Hieber M; Thiel E; Blau IW
Ann Oncol; 2006 Aug; 17(8):1306-12. PubMed ID: 16766594
[TBL] [Abstract][Full Text] [Related]
23. Itraconazole prophylaxis for invasive gingival aspergillosis in neutropenic patients with acute leukemia.
Myoken Y; Sugata T; Kyo T; Fujihara M; Mikami Y
J Periodontol; 2002 Jan; 73(1):33-8. PubMed ID: 11846198
[TBL] [Abstract][Full Text] [Related]
24. Low incidence of invasive aspergillosis in allogeneic stem cell transplant recipients receiving amphotericin B inhalation prophylaxis.
Nihtinen A; Anttila VJ; Ruutu T; Juvonen E; Volin L
Transpl Infect Dis; 2012 Feb; 14(1):24-32. PubMed ID: 21749589
[TBL] [Abstract][Full Text] [Related]
25. Meta-analysis of nebulized amphotericin B to prevent or treat pulmonary aspergillosis in immunosuppressed animals.
Ho KM; Duff O; Chambers D; Murray R
Transpl Infect Dis; 2008 Jun; 10(3):168-76. PubMed ID: 18194368
[TBL] [Abstract][Full Text] [Related]
26. Oral itraconazole plus nasal amphotericin B for prophylaxis of invasive aspergillosis in patients with hematological malignancies.
Todeschini G; Murari C; Bonesi R; Pizzolo G; Amaddi G; Ambrosetti A; Cerù S; Piacentini I; Martini N; Montresor P
Eur J Clin Microbiol Infect Dis; 1993 Aug; 12(8):614-8. PubMed ID: 8223660
[TBL] [Abstract][Full Text] [Related]
27. Treatment of invasive pulmonary aspergillosis in neutropenic patients by additional bronchoscopic amphotericin B instillation.
Winkler J; Müller U; Nenoff P; Seyfarth HJ; Vogtmann M; Borte G; Pönisch W; Kahn T; Wirtz H; Schauer J; Hoheisel G
Respiration; 2007; 74(6):663-73. PubMed ID: 17622755
[TBL] [Abstract][Full Text] [Related]
28. Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group.
Wolff SN; Fay J; Stevens D; Herzig RH; Pohlman B; Bolwell B; Lynch J; Ericson S; Freytes CO; LeMaistre F; Collins R; Pineiro L; Greer J; Stein R; Goodman SA; Dummer S
Bone Marrow Transplant; 2000 Apr; 25(8):853-9. PubMed ID: 10808206
[TBL] [Abstract][Full Text] [Related]
29. Effect of prophylactic fluconazole on the frequency of fungal infections, amphotericin B use, and health care costs in patients undergoing intensive chemotherapy for hematologic neoplasias.
Schaffner A; Schaffner M
J Infect Dis; 1995 Oct; 172(4):1035-41. PubMed ID: 7561177
[TBL] [Abstract][Full Text] [Related]
30. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A
Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575
[TBL] [Abstract][Full Text] [Related]
31. Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia.
Hertenstein B; Kern WV; Schmeiser T; Stefanic M; Bunjes D; Wiesneth M; Novotny J; Heimpel H; Arnold R
Ann Hematol; 1994 Jan; 68(1):21-6. PubMed ID: 8110874
[TBL] [Abstract][Full Text] [Related]
32. Case reports. Invasive pulmonary aspergillosis in non-neutropenic patients treated with liposomal amphotericin B.
Zhirong Y; Wanqing L; Weihua P
Mycoses; 1999; 42(11-12):679-82. PubMed ID: 10680448
[TBL] [Abstract][Full Text] [Related]
33. Invasive aspergillosis in severely neutropenic patients over 18 years: impact of intranasal amphotericin B and HEPA filtration.
Withington S; Chambers ST; Beard ME; Inder A; Allen JR; Ikram RB; Schousboe MI; Heaton DC; Spearing RI; Hart DN
J Hosp Infect; 1998 Jan; 38(1):11-8. PubMed ID: 9513064
[TBL] [Abstract][Full Text] [Related]
34. Preventing fungal infection in neutropenic patients with acute leukemia: fluconazole compared with oral amphotericin B.
Menichetti F; Del Favero A; Martino P; Bucaneve G; Micozzi A; D'Antonio D; Ricci P; Carotenuto M; Liso V; Nosari AM; Barbui T; Fasola G; Mandelli F;
Ann Intern Med; 1994 Jun; 120(11):913-8. PubMed ID: 8172437
[TBL] [Abstract][Full Text] [Related]
35. Amphotericin B nasal spray as prophylaxis against aspergillosis in patients with neutropenia.
Meunier-Carpentier F; Snoeck R; Gerain J; Muller C; Klastersky J
N Engl J Med; 1984 Oct; 311(16):1056. PubMed ID: 6482917
[No Abstract] [Full Text] [Related]
36. Randomized trial of lipid-based amphotericin B for invasive aspergillosis in neutropenic hosts is an important step forward.
Karp JE; Merz WG
Clin Infect Dis; 1998 Dec; 27(6):1413-4. PubMed ID: 9868652
[No Abstract] [Full Text] [Related]
37. Tolerability of prophylactic aerosolized liposomal amphotericin-B and impact on pulmonary function: data from a randomized placebo-controlled trial.
Slobbe L; Boersma E; Rijnders BJ
Pulm Pharmacol Ther; 2008 Dec; 21(6):855-9. PubMed ID: 18951992
[TBL] [Abstract][Full Text] [Related]
38. Antifungal prophylaxis is effective against murine invasive pulmonary aspergillosis.
Rieg G; Spellberg B; Schwartz J; Fu Y; Edwards JE; Sheppard DC; Ibrahim AS
Antimicrob Agents Chemother; 2006 Aug; 50(8):2895-6. PubMed ID: 16870798
[No Abstract] [Full Text] [Related]
39. Aerosolized amphotericin B lipid complex as adjunctive treatment for fungal lung infection in patients with cancer-related immunosuppression and recipients of hematopoietic stem cell transplantation.
Safdar A; Rodriguez GH
Pharmacotherapy; 2013 Oct; 33(10):1035-43. PubMed ID: 23784915
[TBL] [Abstract][Full Text] [Related]
40. A double-blind, randomized, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients.
Nucci M; Biasoli I; Akiti T; Silveira F; Solza C; Barreiros G; Spector N; Derossi A; Pulcheri W
Clin Infect Dis; 2000 Feb; 30(2):300-5. PubMed ID: 10671332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
